You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid vaccination Phase-II: Check if you are eligible to get a shot

If you are above 45 years old and have one of co-morbidities listed by the govt, you could get a coronavirus vaccine in this phase-2 of vaccination drive. Here's the full list of health issues

Topics
Coronavirus Vaccine | Bharat Biotech | Coronavirus

BS Web Team  |  New Delhi 

covid vaccine, coronavirus
A man receives a Bharat Biotech's Covid-19 vaccine called COVAXIN, at a vaccination centre, in New Delhi. Photo: Reuters

The second phase of India’s Covid-19 vaccination started on Monday and the Co-WIN portal also started a self-registration process for the 270 million people eligible for these shots. Under this phase, people above 60 years of age – and those over 45 years of age and with co-morbidities – are to be inoculated. The registration portal could be accessed at https://selfregistration.cowin.gov.in/.

The government has issued a list of 20 specified co-morbidities to determine the eligibility of people who can be administered a vaccine shot on priority.

If someone is more than 45 years old and suffers from conditions like diabetes or has suffered a heart attack in the past year, they will be eligible to get a Covid-19 vaccine shot. Here’s the full list of specified co-morbidities:

1. Heart failure with hospital admission in the past one year.

2. Post cardiac transplant/ Left Ventricular Assist Device (LVAD).

3. Significant left ventricular systolic dysfunction (LVEF < 40%).

4. Moderate or severe valvular heart disease.

5. Congenital heart disease with severe PAH or Idiopathic PAH.

6. Coronary artery disease with past CABG/ PTCA/ MI And hypertension/diabetes on treatment.

7. Angina and hypertension/ diabetes treatment.

8. CT/MRI documented stroke and hypertension/diabetes on treatment.

9. Pulmonary artery hypertension and hypertension/diabetes on treatment

10. Diabetes (>10 years or with complication) and hypertension on treatment

11. Kidney/Liver/Hematopoietic stem cell transplant: Recipient/on wait-list

12. End stage kidney disease on haemodialysis/CAPD

13. Current prolonged use of oral corticosteroids/immunosuppressant medications.

14. Decompensated cirrhosis.

15. Severe respiratory disease with hospitalisations in last two years/ FEVI <50%.

16. Lymphoma/Leukaemia/Myeloma

17. Diagnosis of any solid cancer on or after July 1,2020 OR currently on any cancer therapy.

18. Sickle Cell Disease/Bone marrow failure/Aplastic Anemia/Thalassemia Major

19. Primary Immunodeficiency Diseases/HIV infection

20. Persons with disabilities due to intellectual disabilities/muscular dystrophy/acid attack with involvement of respiratory system/Persons with disabilities having high support needs/multiple disabilities including deaf-blindness.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, March 01 2021. 12:35 IST
RECOMMENDED FOR YOU